Details for New Drug Application (NDA): 209489
✉ Email this page to a colleague
The generic ingredient in CASPOFUNGIN ACETATE is caspofungin acetate. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the caspofungin acetate profile page.
Summary for 209489
Tradename: | CASPOFUNGIN ACETATE |
Applicant: | Cipla |
Ingredient: | caspofungin acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 50MG/VIAL | ||||
Approval Date: | Jul 12, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 70MG/VIAL | ||||
Approval Date: | Jul 12, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription